论文部分内容阅读
The crystal structure determination and mass spectrometric fragmentation analysis of the medicinal ingredient eprosartan(4-[2-butyl-5-(2-carboxy-3-thiophen-2-yl-propenyl)-imi-dazol-1-ylmethyl]-benzoic acid) are presented.The single-crystal X-ray diffracti